Back to dashboard
MedicaidPrior AuthMedium impact

Vyloy (zolbetuximab-clzb) (New)

Humana·LA · Infectious Disease, Gastroenterology·Medicaid
Effective date
Not stated
We identified it
Jul 23, 2026
Days to comply

Summary

Humana Medicaid in Louisiana has issued a new Prior Authorization policy for Vyloy (zolbetuximab-clzb), a monoclonal antibody treatment. Billing teams must obtain prior authorization before administering this drug to Louisiana Medicaid members to avoid claim denials.

Action Required

Action needed
Immediately: Billing and clinical teams must implement prior authorization requirements for Vyloy (zolbetuximab-clzb) for all Louisiana Medicaid members. (1) Contact Humana at the source URL or member services to obtain the complete policy details, including specific authorization criteria, required documentation, and submission procedures. (2) Update billing system to flag Vyloy claims for prior authorization submission before claim submission. (3) Providers must submit prior authorization requests with required clinical documentation before administering the drug. (4) Train front desk and billing staff to verify prior authorization status before scheduling or billing. Failure to obtain prior authorization will result in claim denials and potential member balance issues.